RxDoctor Payments DataLook up a doctor →

Liana Billings, MD

Endocrinology, Diabetes & Metabolism · Skokie, ILNPI 1457528101

Payments from drug & device makers

$3,435,038in general payments, 2019–2025

Across 2,243 payments — averaging $1531.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$1.6M
  • Eli Lilly$587K
  • Amgen$330K
  • Sanofi US Services Inc.$302K
  • Novo Nordisk$162K
  • Medtronic$125K
  • plus $304K from 9 others
$16,029in research payments, 2019–2025

Across 10 payments — averaging $1602.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$10K
  • Novo Nordisk$4K
  • Eli Lilly$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk AS1,800$1,624,846
Eli Lilly78$587,129
Amgen7$330,153
Sanofi US Services Inc.26$301,836
Novo Nordisk117$161,751
Medtronic20$125,424
Sequel Med Tech, LLC150$120,467
Sanofi5$52,536
AstraZeneca2$49,492
Sanofi-aventis U.S. LLC18$46,063
Dexcom, Inc.10$24,809
Bayer6$8,959
Xeris Pharmaceuticals, Inc.2$1,155
Pfizer1$375
Mannkind Corporation1$43

How this compares

$3,435,038 in reported general payments places this provider in the 95th percentile of 347 endocrinology, diabetes & metabolism providers in Illinois.

See all endocrinology, diabetes & metabolism providers in Illinois

Medicare billing

Part B allowed, 2024
$30,141
Medicare patients
143
Services billed
341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Skokie

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →